Articles by PETER LOFTUShttp://labs.daylife.com/journalist/peter_loftusArticles by PETER LOFTUS, aggregated by daylife.comen-usTue, 24 Nov 2009 10:40:46 GMTTue, 24 Nov 2009 10:40:46 GMTDaylife Betaken@daylife.comken@daylife.comMerck’s Clark on PR Woes: ‘I Can’t Blame the Media’http://feeds.wsjonline.com/~r/wsj/health/feed/~3/281659037/WSJ’s blog on health and the business of health. At a Morgan Stanley conference today, Clark was asked about all the bad press the company has been getting: Is Merck not providing the positive stories or are the media not interested? “The answer to ...Thu, 01 May 2008 20:56:39 GMThttp://feeds.wsjonline.com/~r/wsj/health/feed/~3/281659037/Merck & Company, Inc.Morgan StanleyWyeth Dogged by Prevnar Manufacturing Lawsuitshttp://feeds.wsjonline.com/~r/wsj/health/feed/~3/243500927/Wyeth can’t seem to shake allegations of past manufacturing improprieties with its blockbuster vaccine Prevnar. The drug maker’s annual report, filed this morning, disclosed that two former Wyeth employees accused the drug maker of making false claims ...Fri, 29 Feb 2008 19:57:57 GMThttp://feeds.wsjonline.com/~r/wsj/health/feed/~3/243500927/U.S. Department of JusticeSepracor rises on renewed takeover speculationhttp://www.boston.com/news/local/massachusetts/articles/2006/06/19/sepracor_rises_on_renewed_takeover_speculation?rss_id=Boston.com+--+Massachusetts+newsstock rose Monday on renewed speculation that the pharmaceutical company might be acquired by a larger rival. Shares of Marlborough, Mass.-based Sepracor, which markets the insomnia drug Lunesta, closed up $4.63, or 9.3 percent, to $54.15 ...Mon, 19 Jun 2006 22:32:03 GMThttp://www.boston.com/news/local/massachusetts/articles/2006/06/19/sepracor_rises_on_renewed_takeover_speculation?rss_id=Boston.com+--+Massachusetts+news